Showing 1 - 9 results of 9 for search 'Peris, K', query time: 2.32s
Refine Results
-
1
Targeting IL-4 for the Treatment of Atopic Dermatitis by Chiricozzi A, Maurelli M, Peris K, Girolomoni G
Published 2020-09-01
Article -
2
-
3
-
4
-
5
-
6
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline. by Garbe, C, Peris, K, Hauschild, A, Saiag, P, Middleton, M, Spatz, A, Grob, J, Malvehy, J, Newton-Bishop, J, Stratigos, A, Pehamberger, H, Eggermont, A
Published 2010Journal article -
7
Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy by Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L
Published 2021-11-01
Article -
8
Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines by Peris, K, Fargnoli, MC, Garbe, C, Kaufmann, R, Bastholt, L, Seguin, NB, Bataille, V, Marmol, VD, Dummer, R, Harwood, CA, Hauschild, A, Höller, C, Haedersdal, M, Malvehy, J, Middleton, MR, Morton, CA, Nagore, E, Stratigos, AJ, Szeimies, RM, Tagliaferri, L, Trakatelli, M, Zalaudek, I, Eggermont, A, Grob, JJ, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)
Published 2019Journal article -
9
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study by Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E
Published 2023-12-01
Article